We are live on
!
Find out more
Arcturus Therapeutics
ARCT
ARCT
147 hedge funds and large institutions have $453M invested in Arcturus Therapeutics in 2024 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 55 increasing their positions, 47 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
17% more repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 47
1.3% more ownership
Funds ownership: 97.1% → 98.39% (+1.3%)
1% less call options, than puts
Call options by funds: $2.94M | Put options by funds: $2.98M
10% less funds holding
Funds holding: 164 → 147 (-17)
26% less capital invested
Capital invested by funds: $609M → $453M (-$157M)
52% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 31
Holders
147
Holders Change
-17
Holders Change %
-10.37%
% of All Funds
1.94%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
55
Reduced
47
Closed
31
Calls
$2.94M
Puts
$2.98M
Net Calls
-$39K
Net Calls Change
-$1.7M
Top Buyers
| 1 |
Balyasny Asset Management
Chicago,
Illinois
|
+$10.3M |
| 2 |
SSA
Schonfeld Strategic Advisors
New York
|
+$9.03M |
| 3 |
JGC
J. Goldman & Co
New York
|
+$5.57M |
| 4 |
Morgan Stanley
New York
|
+$5.11M |
| 5 |
MB
MPM BioImpact
Boston,
Massachusetts
|
+$4.53M |
Top Sellers
| 1 |
Millennium Management
New York
|
-$5.48M |
| 2 |
NAMA
Nikko Asset Management Americas
New York
|
-$4.71M |
| 3 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
-$3.97M |
| 4 |
RA
Royce & Associates
New York
|
-$3.62M |
| 5 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$3.15M |
